Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature

Archives Italiennes de Biologie

Volumn 149, Issue 3, 2011, Pages 318-322

  Mancuso, M ^a   Orsucci, D ^a   Bacci, A ^a   Ienco, E Caldarazzo ^a   Siciliano, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Anti Ri; Nystagmus; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Pcd; Pet

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; NERVE PROTEIN; NOVA ANTIGEN; RNA BINDING PROTEIN; TUMOR ANTIGEN;

ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOLOGY; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; NYSTAGMUS; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, NEOPLASM; GAIT DISORDERS, NEUROLOGIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NYSTAGMUS, PATHOLOGIC; PARANEOPLASTIC CEREBELLAR DEGENERATION; POSITRON-EMISSION TOMOGRAPHY; RNA-BINDING PROTEINS; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA;

EID: 80155188536     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Buckanovich R.J., Posner J.B., Darnell R.B. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron, 11: 657-672, 1993.
2. Budde-Steffen C., Anderson N.E., Rosenblum M.K., Graus F., Ford D., Synek B.J., Wray S.H., Posner J.B. An antineuronal autoantibody in paraneoplastic opsoclonus. Ann. Neurol., 23: 528-531, 1988.
3. Drlicek M., Bianchi G., Bogliun G., Casati B., Grisold W., Kolig C., Liszka-Setinek U., Marzorati L., Wondrusch E., Cavaletti G. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J. Neurol., 244: 85-89, 1997.
4. Escudero D., Barnadas A., Codina M., Fueyo J., Graus F. Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer. Neurology, 43: 1605-1606, 1993.
5. Fumal A., Jobe J., Pepin J.L., Delvaux V., Senterre J.M., Bonaventure S., de Noordhout A.M. Intravenous immunoglobulins in paraneoplastic brainstem encephalitis with anti-Ri antibodies. J. Neurol., 253: 1360-1361, 2006.
6. Jarius S., Stich O., Rasiah C., Voltz R., Rauer S. Qualitative evidence of Ri specific IgG-synthesis in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. J. Neurol. Sci., 268: 65-68, 2008.
7. Kim H., Lim Y., Kim K.K. Anti-ri-antibodyassociated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI. J. Clin. Neurol., 5: 151-152, 2009.
8. Knudsen A., Monstad S.E., Dorum A., Lonning P.E., Salvesen H.B., Drivsholm L., Aarseth J.H., Vedeler C.A. Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique. Cancer Immunol. Immunother., 55: 1280-1284, 2006.
9. Luque F.A., Furneaux H.M., Ferziger R., Rosenblum M.K., Wray S.H., Schold S.C., Jr., Glantz M.J., Jaeckle K.A., Biran H., Lesser M., et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol., 29: 241-251, 1991.
10. McCabe D.J., Turner N.C., Chao D., Leff A., Gregson N.A., Womersley H.J., Mak I., Perkin G.D., Schapira A.H. Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies. Neurology, 62: 1402-1404, 2004.
11. Monstad S.E., Knudsen A., Salvesen H.B., Aarseth J.H., Vedeler C.A. Onconeural antibodies in sera from patients with various types of tumours. Cancer Immunol. Immunother., 58: 1795-1800, 2009.
12. Pittock S.J., Lucchinetti C.F., Lennon V.A. Antineuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann. Neurol., 53: 580-587, 2003.
13. Prestigiacomo C.J., Balmaceda C., Dalmau J. Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma. Cancer, 91: 1423-1428, 2001.
14. Shams'ili S., Grefkens J., de Leeuw B., van den Bent M., Hooijkaas H., van der Holt B., Vecht C., Sillevis Smitt P. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain, 126: 1409-1418, 2003.
15. Stich O., Rasiah C., Rauer S. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome. Acta Neurol. Scand., 119: 338-340, 2009.
16. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol., 1: 294-305, 2002.
17. Voltz R. Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes. J. Neurol., 253 Suppl 5: V33-38, 2006.
18. Wirtz P.W., Sillevis Smitt P.A., Hoff J.I., de Leeuw B., Lammers G.J., van Duinen S.G., Verschuuren J.J. Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma. J. Neurol., 249: 1710-1712, 2002.
19. Yang Y.Y., Yin G.L., Darnell R.B. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc. Natl. Acad. Sci. USA, 95: 13254-13259, 1998.
20. Younes-Mhenni S., Janier M.F., Cinotti L., Antoine J.C., Tronc F., Cottin V., Ternamian P.J., Trouillas P., Honnorat J. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain, 127: 2331-2338, 2004.